BEAM
Price
$23.13
Change
+$0.41 (+1.80%)
Updated
May 3, 6:59 PM EST
One day until earnings call
INZY
Price
$4.74
Change
+$0.09 (+1.94%)
Updated
May 3, 6:59 PM EST
One day until earnings call
Ad is loading...

Compare trend and price BEAM vs INZY

Header iconBEAM vs INZY Comparison
Open Charts BEAM vs INZYBanner chart's image
Beam Therapeutics
Price$23.13
Change+$0.41 (+1.80%)
Volume$634.55K
CapitalizationN/A
Inozyme Pharma
Price$4.74
Change+$0.09 (+1.94%)
Volume$204.54K
CapitalizationN/A
View a ticker or compare two or three
BEAM vs INZY Comparison Chart

Loading...

BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
INZYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BEAM vs. INZY commentary
May 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Hold and INZY is a Hold.

COMPARISON
Comparison
May 06, 2024
Stock price -- (BEAM: $23.13 vs. INZY: $4.74)
Brand notoriety: BEAM and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 86% vs. INZY: 44%
Market capitalization -- BEAM: $1.9B vs. INZY: $293.2M
BEAM [@Biotechnology] is valued at $1.9B. INZY’s [@Biotechnology] market capitalization is $293.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $545.88B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileINZY’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • INZY’s FA Score: 1 green, 4 red.
According to our system of comparison, INZY is a better buy in the long-term than BEAM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while INZY’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • INZY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than INZY.

Price Growth

BEAM (@Biotechnology) experienced а +8.19% price change this week, while INZY (@Biotechnology) price change was +6.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was -3.94%, and the average quarterly price growth was +1240.85%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 06, 2024.

INZY is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for INZY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($1.9B) has a higher market cap than INZY($293M). INZY YTD gains are higher at: 11.268 vs. BEAM (-15.026).
BEAMINZYBEAM / INZY
Capitalization1.9B293M650%
EBITDAN/AN/A-
Gain YTD-15.02611.268-133%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
BEAMINZY
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
MACD
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
85%
Declines
ODDS (%)
Bearish Trend 11 days ago
87%
Bearish Trend 7 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 5 days ago
80%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
INZYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GEMUX23.040.28
+1.23%
Goldman Sachs Emerging Markets Eq R6
MATFX12.400.13
+1.06%
Matthews Asia Innovators Investor
FMFAX99.050.79
+0.80%
Fidelity Advisor Materials A
ALMZX22.870.16
+0.70%
Alger MidCap Growth Institutional Z-2
TRPIX45.710.30
+0.66%
T. Rowe Price Value I

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with NTLA. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+1.80%
NTLA - BEAM
77%
Closely correlated
+1.42%
DNLI - BEAM
69%
Closely correlated
+1.96%
EDIT - BEAM
63%
Loosely correlated
+0.89%
PRME - BEAM
63%
Loosely correlated
-0.36%
VERV - BEAM
61%
Loosely correlated
+4.23%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
+1.94%
BEAM - INZY
54%
Loosely correlated
+1.80%
NTLA - INZY
50%
Loosely correlated
+1.42%
DNLI - INZY
47%
Loosely correlated
+1.96%
PCVX - INZY
45%
Loosely correlated
+2.18%
STOK - INZY
44%
Loosely correlated
+2.82%
More